NO984370L - Propofol-smÕdrÕpeformuleringer - Google Patents

Propofol-smÕdrÕpeformuleringer

Info

Publication number
NO984370L
NO984370L NO984370A NO984370A NO984370L NO 984370 L NO984370 L NO 984370L NO 984370 A NO984370 A NO 984370A NO 984370 A NO984370 A NO 984370A NO 984370 L NO984370 L NO 984370L
Authority
NO
Norway
Prior art keywords
propofol
pml
devoid
surrounded
volume
Prior art date
Application number
NO984370A
Other languages
English (en)
Other versions
NO984370D0 (no
NO324498B1 (no
Inventor
Duncan H Haynes
Original Assignee
Res Triangle Pharm Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=24469788&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO984370(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Res Triangle Pharm Ltd filed Critical Res Triangle Pharm Ltd
Publication of NO984370D0 publication Critical patent/NO984370D0/no
Publication of NO984370L publication Critical patent/NO984370L/no
Publication of NO324498B1 publication Critical patent/NO324498B1/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/045Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05Phenols
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/107Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00Anaesthetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Dispersion Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Anesthesiology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Motorcycle And Bicycle Frame (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Fats And Perfumes (AREA)
NO19984370A 1996-03-19 1998-09-18 Mikro-smadrape og steril injiserbar farmasoytisk blanding NO324498B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/616,511 US5637625A (en) 1996-03-19 1996-03-19 Propofol microdroplet formulations
PCT/US1997/004168 WO1997034588A1 (en) 1996-03-19 1997-03-17 Propofol microdroplet formulations

Publications (3)

Publication Number Publication Date
NO984370D0 NO984370D0 (no) 1998-09-18
NO984370L true NO984370L (no) 1998-09-18
NO324498B1 NO324498B1 (no) 2007-10-29

Family

ID=24469788

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19984370A NO324498B1 (no) 1996-03-19 1998-09-18 Mikro-smadrape og steril injiserbar farmasoytisk blanding

Country Status (19)

Country Link
US (1) US5637625A (no)
EP (1) EP0796616B1 (no)
JP (1) JP2000507244A (no)
KR (1) KR100484516B1 (no)
CN (1) CN1124845C (no)
AT (1) ATE182074T1 (no)
AU (1) AU719756B2 (no)
BR (1) BR9708099B8 (no)
CA (1) CA2249375C (no)
DE (1) DE69700317T2 (no)
DK (1) DK0796616T3 (no)
ES (1) ES2135969T3 (no)
FI (1) FI982009A (no)
GR (1) GR3031414T3 (no)
HU (1) HU225046B1 (no)
NO (1) NO324498B1 (no)
NZ (1) NZ331669A (no)
RU (1) RU2186564C2 (no)
WO (1) WO1997034588A1 (no)

Families Citing this family (62)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6749868B1 (en) 1993-02-22 2004-06-15 American Bioscience, Inc. Protein stabilized pharmacologically active agents, methods for the preparation thereof and methods for the use thereof
US20070117862A1 (en) * 1993-02-22 2007-05-24 Desai Neil P Novel formulations of pharmacological agents, methods for the preparation thereof and methods for the use thereof
EP0855906B1 (en) 1995-10-17 2008-02-20 Jagotec AG Insoluble drug delivery
US6465016B2 (en) * 1996-08-22 2002-10-15 Research Triangle Pharmaceuticals Cyclosporiine particles
US7255877B2 (en) * 1996-08-22 2007-08-14 Jagotec Ag Fenofibrate microparticles
CH692322A5 (it) * 1997-05-26 2002-05-15 Westy Ag Formulazione iniettabile limpida di Propofol.
NZ502500A (en) * 1997-06-27 2002-03-28 Vivorx Pharmaceuticals Inc Novel formulations of pharmacological agents, methods for the preparation thereof and methods for the use thereof
US6638621B2 (en) * 2000-08-16 2003-10-28 Lyotropic Therapeutics, Inc. Coated particles, methods of making and using
BR9907832A (pt) 1998-02-10 2000-10-31 Sicor Inc Composição de propofol contendo sulfito
ES2201673T3 (es) * 1998-02-11 2004-03-16 Rtp Pharma Corporation Combinacion de esteroides y acidos grasos poiinsaturados para el tratamiento de estados inflamatorios.
US6254853B1 (en) * 1998-05-08 2001-07-03 Vyrex Corporation Water soluble pro-drugs of propofol
DK1079808T3 (da) 1998-05-29 2004-06-07 Skyepharma Canada Inc Præparater med termisk beskyttede mikropartikler og fremgangsmåde til slutdampsterilisering deraf
US6204257B1 (en) 1998-08-07 2001-03-20 Universtiy Of Kansas Water soluble prodrugs of hindered alcohols
ATE252889T1 (de) * 1998-08-19 2003-11-15 Skyepharma Canada Inc Injizierbare wässerige propofoldispersionen
US6150423A (en) 1998-10-15 2000-11-21 Phoenix Scientific, Inc. Propofol-based anesthetic and method of making same
US6140374A (en) * 1998-10-23 2000-10-31 Abbott Laboratories Propofol composition
BR9915738A (pt) 1998-11-20 2001-10-02 Rtp Pharma Inc Micropartìculas estabilizadas em fosfolipìdeos dispersìveis
ES2232195T3 (es) * 1999-01-28 2005-05-16 Dinesh Shantilal Patel Solucion parenteral de propofol (2,6-diisopropilfenol) y 2,5-di-o-metil-1,4;3,6-dianhidro-d-glucitol como solvente.
US6177477B1 (en) * 1999-03-24 2001-01-23 American Home Products Corporation Propofol formulation containing TRIS
US6100302A (en) * 1999-04-05 2000-08-08 Baxter International Inc. Propofol formulation with enhanced microbial characteristics
GB2350297A (en) * 1999-05-27 2000-11-29 Abbott Lab Injectable halogenated anesthetic formulation in emulsion form
DE60020382T2 (de) * 1999-09-21 2006-01-26 Skyepharma Canada Inc., Verdun Oberflächenmodifizierte teilchenförmige zusammensetzungen biologisch aktiver stoffe
US6071933A (en) * 1999-12-03 2000-06-06 Diversified Medical Innovations, Inc. Homogeneous remifentanil-propofol blend for patient controlled anesthesia and process for its use
GB2359747B (en) 2000-02-29 2002-04-24 Maelor Pharmaceuticals Ltd Anaesthetic formulations
CA2407027C (en) 2000-04-20 2011-02-15 Rtp Pharma Inc. Improved water-insoluble drug particle process
WO2001097779A2 (en) 2000-06-16 2001-12-27 Rtp Pharma Inc. Improved injectable dispersions of propofol
US6623765B1 (en) * 2000-08-01 2003-09-23 University Of Florida, Research Foundation, Incorporated Microemulsion and micelle systems for solubilizing drugs
CA2420597C (en) 2000-08-31 2011-05-17 Rtp Pharma Inc. Milled particles
NZ525231A (en) * 2000-09-20 2004-08-27 Skyepharma Canada Inc Phospholipid stabilised feno-fibrate microparticles for pharmaceutical use
US8586094B2 (en) 2000-09-20 2013-11-19 Jagotec Ag Coated tablets
CN1273112C (zh) * 2001-02-22 2006-09-06 斯凯伊药品加拿大公司 具有减少进食-禁食作用的贝特-它汀组合
WO2003000236A1 (en) 2001-06-23 2003-01-03 Lyotropic Therapeutics, Inc Particles with improved solubilization capacity
US20030054042A1 (en) * 2001-09-14 2003-03-20 Elaine Liversidge Stabilization of chemical compounds using nanoparticulate formulations
WO2003026632A2 (en) 2001-09-26 2003-04-03 Theravance, Inc. Substituted phenol compounds useful for anesthesia and sedation
CN1558755A (zh) * 2001-09-26 2004-12-29 ���ع��ʹ�˾ 通过分散和除去溶剂或液相制备亚微米大小的纳米颗粒
US7112340B2 (en) * 2001-10-19 2006-09-26 Baxter International Inc. Compositions of and method for preparing stable particles in a frozen aqueous matrix
CA2470500C (en) * 2001-12-28 2012-05-15 Guilford Pharmaceuticals, Inc. Aqueous based pharmaceutical formulations of water-soluble prodrugs of propofol
AU2003230691A1 (en) * 2002-03-20 2003-10-08 Elan Pharma International Ltd. Nanoparticulate compositions of angiogenesis inhibitors
US20080220075A1 (en) * 2002-03-20 2008-09-11 Elan Pharma International Ltd. Nanoparticulate compositions of angiogenesis inhibitors
PL373850A1 (en) * 2002-04-08 2005-09-19 Guilford Pharmaceuticals, Inc. Pharmaceutical compositions containing water-soluble prodrugs of propofol and methods of administering same
US20040220283A1 (en) * 2002-07-29 2004-11-04 Transform Pharmaceuticals, Inc. Aqueous 2,6-diisopropylphenol pharmaceutical compositions
US7550155B2 (en) * 2002-07-29 2009-06-23 Transform Pharmaceuticals Inc. Aqueous pharmaceutical compositions of 2,6-diisopropylphenol (propofol) and their uses
AU2003261274C1 (en) * 2002-07-29 2009-02-12 Transform Pharmaceuticals, Inc. Aqueous 2,6-diisopropylphenol pharmaceutical compositions
JP2006504771A (ja) * 2002-10-29 2006-02-09 トランスフォーム・ファーマシューティカルズ・インコーポレイテッド システインを伴うプロポフォール
JPWO2004052354A1 (ja) * 2002-12-06 2006-04-06 株式会社大塚製薬工場 プロポフォール含有脂肪乳剤
US20040225022A1 (en) * 2003-05-09 2004-11-11 Desai Neil P. Propofol formulation containing reduced oil and surfactants
US8476010B2 (en) 2003-07-10 2013-07-02 App Pharmaceuticals Llc Propofol formulations with non-reactive container closures
US7182948B2 (en) * 2003-08-04 2007-02-27 Ko Manufacturing, Inc. Topical veterinary compositions and methods for the treatment and prevention of infection
US20090060998A1 (en) * 2004-01-14 2009-03-05 Gilead Sciences, Inc. Lipid-based dispersions useful for drug delivery
US7125954B2 (en) 2005-01-27 2006-10-24 General Electric Company Method for producing polyether polymers
MX2007015183A (es) * 2005-06-14 2008-02-19 Baxter Int Formulaciones farmaceuticas para minimizar las interacciones farmaco-farmaco.
KR101643416B1 (ko) * 2005-08-31 2016-07-27 아브락시스 바이오사이언스, 엘엘씨 증가된 안정성을 가진 수 난용성 약물의 조성물 및 제조방법
RU2451510C2 (ru) * 2005-08-31 2012-05-27 АБРАКСИС БАЙОСАЙЕНС, ЭлЭлСи Композиции и способы получения слаборастворимых в воде лекарственных средств с увеличенной стабильностью
EP1954245A2 (en) * 2005-11-15 2008-08-13 Baxter International Inc. Compositions of lipoxygenase inhibitors
US8426467B2 (en) 2007-05-22 2013-04-23 Baxter International Inc. Colored esmolol concentrate
US8722736B2 (en) * 2007-05-22 2014-05-13 Baxter International Inc. Multi-dose concentrate esmolol with benzyl alcohol
RU2535001C1 (ru) * 2013-07-11 2014-12-10 Общество с ограниченной ответственностью "ВИК-здоровье животных" Микроколлоидный раствор пропофола для анестезии
US20160346219A1 (en) 2015-06-01 2016-12-01 Autotelic Llc Phospholipid-coated therapeutic agent nanoparticles and related methods
EP3302433A4 (en) * 2015-06-01 2019-01-23 Autotelic LLC THERAPEUTIC AGENT NANOPARTICLES COATED WITH PHOSPHOLIPID AND ASSOCIATED METHODS
WO2017218630A2 (en) * 2016-06-15 2017-12-21 Autotelic Llc Phospholipid-coated therapeutic agent nanoparticles and related methods
EP4076384A1 (de) * 2019-12-20 2022-10-26 Fresenius Kabi Austria GmbH Verfahren zur herstellung von öl-in-wasser-emulsionen
EP4056038A1 (en) * 2021-03-10 2022-09-14 Basf Se Microparticles containing active substances

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1472793A (en) * 1974-03-28 1977-05-04 Ici Ltd Pharmaceutical compositions
US4798846A (en) * 1974-03-28 1989-01-17 Imperial Chemical Industries Plc Pharmaceutical compositions
US4725442A (en) * 1983-06-17 1988-02-16 Haynes Duncan H Microdroplets of water-insoluble drugs and injectable formulations containing same
US4622219A (en) * 1983-06-17 1986-11-11 Haynes Duncan H Method of inducing local anesthesia using microdroplets of a general anesthetic
DE4132677C2 (de) * 1991-10-01 1995-08-24 Braun Melsungen Ag Flüchtige Inhalationsnarkotika enthaltende Liposomen, ihre Herstellung und Verwendung
GB9405593D0 (en) * 1994-03-22 1994-05-11 Zeneca Ltd Pharmaceutical compositions
US5496537A (en) * 1995-03-23 1996-03-05 Henry; Richard A. Propofol hydrofluorocarbon propellant formulations

Also Published As

Publication number Publication date
NO984370D0 (no) 1998-09-18
EP0796616B1 (en) 1999-07-14
WO1997034588A1 (en) 1997-09-25
ES2135969T3 (es) 1999-11-01
HU225046B1 (hu) 2006-05-29
ATE182074T1 (de) 1999-07-15
BR9708099B1 (pt) 2010-02-23
FI982009A0 (fi) 1998-09-17
CA2249375C (en) 2002-06-18
CA2249375A1 (en) 1997-09-25
DE69700317T2 (de) 1999-12-02
AU2329297A (en) 1997-10-10
FI982009A (fi) 1998-09-17
NZ331669A (en) 2000-01-28
NO324498B1 (no) 2007-10-29
BR9708099A (pt) 2000-01-04
HUP9902553A2 (hu) 2000-10-28
BR9708099B8 (pt) 2014-04-29
DK0796616T3 (da) 1999-11-29
GR3031414T3 (en) 2000-01-31
KR20000064762A (ko) 2000-11-06
US5637625A (en) 1997-06-10
HUP9902553A3 (en) 2001-04-28
DE69700317D1 (de) 1999-08-19
AU719756B2 (en) 2000-05-18
RU2186564C2 (ru) 2002-08-10
CN1218398A (zh) 1999-06-02
CN1124845C (zh) 2003-10-22
EP0796616A1 (en) 1997-09-24
JP2000507244A (ja) 2000-06-13
KR100484516B1 (ko) 2005-09-02

Similar Documents

Publication Publication Date Title
NO984370L (no) Propofol-smÕdrÕpeformuleringer
CA2207218A1 (en) Controlled release composition forming a reversed micellar (l2) structure or a normal micellar (l1) structure
RU98118914A (ru) Изготовление лекарственных средств из микрокапель пропофола
CA2304122A1 (en) Stable cosmetic compositions with different ph emulsions
WO1996028131A3 (de) Kosmetische oder pharmazeutische mikroemulsionen
CA2206602A1 (en) Sequential delivery of purified biological and chemical reagents
CA2139625A1 (en) A microencapsulated oil or fat product
KR100414853B1 (no)
KR910005760A (ko) 살충제 및/또는 살비제 조성물
CA2155763A1 (en) Cosmetic compositions
ES2147784T3 (es) Mejoras en o relacionadas con un agente de contraste.
MXPA97007996A (es) Preparado para el transporte de sustancias activas a traves de barreras.
MX9500133A (es) Emulsiones de agua/aceite de alta fase interna.
KR970014571A (ko) 1,2-디브로모-2,4-디시아노부탄과 파라하이드록시벤조산 에스테르와의 상승작용성 항미생물성 조성물
AU6460399A (en) Method for producing a biological substance, biological substance and the use thereof
KR950702385A (ko) 콜레토트리컴 속균 및 그 용도
CA2220178A1 (en) Dry preparations containing microbially produced oil
KR900001370A (ko) 이부딜라스트 지질 미세구 및 그의 제조방법
CA2169657A1 (fr) Procede de rehabilitation de sols contamines par hydrocarbures et autres substances biodegradables
WO1999004749A3 (de) Multiple w/o/w-emulsionen mit hohem polyolgehalt
RU95107066A (ru) Композиционный гуминокремнеземный сорбент
KR970009793A (ko) 이부프로펜 용액을 함유한 연질캅셀제
TH5419B (th) สารผสมฆ่าศัตรูพืชศัตรูสัตว์ที่เสถียร
KR900005876A (ko) 농원예용 살충제 조성물
KR950005161A (ko) 안정한 제초제 배합 조성물

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees